Before the sun even came up on the Houston offices of EncysivePharmaceuticals last Monday, Chief Executive BruceGivenBruce Given got on a conference call with edgy financial analysts.
On the same day that Encysive got its bad news, Cubist Pharmaceuticals (nasdaq: CBST - news - people ) announced a two-month delay on a key new marketing claim for its antibiotic.